Probiotics may alleviate symptoms of hay fever, which may be related to bacteria in our gut and nose.

Published Date: 26 Apr 2023

The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.

Read Full News

Latest News

Does High-Dose Vitamin D3 Supplementation Improve CRC Survival?

A phase 3 trial was conducted to confirm the benefit of high-dose vitamin D3 supplementation in patients with previously untreated metastatic CRC that was seen in a phase 2 trial.

IV Vitamin C With Chemo Shows Signals in Cancer Care

A phase 2 study reported a longer median overall survival in patients receiving IV ascorbate with chemotherapy, although larger randomized trials are needed to confirm the finding.

Small Colorectal Lesions Carry Risk for Deep Invasion

Non-pedunculated colorectal lesions smaller than 2 cm may harbor deep submucosal invasion despite their diminutive size, study finds.

Etrasimod Effective As First-Line Advanced UC Therapy

Etrasimod can be an effective and safe first-line advanced therapy option in patients with ulcerative colitis who escalate after conventional treatment failure.

Does Doublet Chemotherapy Improve Survival in Rectal Cancer?

Patients with high-risk locally advanced rectal cancer were randomly assigned to receive doublet-LC TNT or conventional neoadjuvant chemoradiotherapy.

Radiation Boost Linked to Better Survival in Rectal Cancer

A phase 2 trial finds that adding a modest radiation boost improves 9-year survival without increasing toxicity, despite no improvement in pathologic complete response.

Todays Updates

Gatekeeping May Reduce Pediatric Cancer Trial Participation

Researchers query parents of children with cancer and clinicians on barriers and facilitators to participation in clinical trials.

AI Framework Helps Classify Renal Tumors, Predict Outcomes

A deep learning system trained on whole-slide images classifies nine renal tumor subtypes with high accuracy and outperforms traditional grading in predicting patient outcomes.

Todays Updates

Gatekeeping May Reduce Pediatric Cancer Trial Participation

Researchers query parents of children with cancer and clinicians on barriers and facilitators to participation in clinical trials.

AI Framework Helps Classify Renal Tumors, Predict Outcomes

A deep learning system trained on whole-slide images classifies nine renal tumor subtypes with high accuracy and outperforms traditional grading in predicting patient outcomes.

Latest News

A phase 3 trial was conducted to confirm the benefit of high-dose vitamin D3 supplementation in patients with previously untreated metastatic CRC that was seen in a phase 2 trial.

A phase 2 study reported a longer median overall survival in patients receiving IV ascorbate with chemotherapy, although larger randomized trials are needed to confirm the finding.

Non-pedunculated colorectal lesions smaller than 2 cm may harbor deep submucosal invasion despite their diminutive size, study finds.

Etrasimod can be an effective and safe first-line advanced therapy option in patients with ulcerative colitis who escalate after conventional treatment failure.

Patients with high-risk locally advanced rectal cancer were randomly assigned to receive doublet-LC TNT or conventional neoadjuvant chemoradiotherapy.

A phase 2 trial finds that adding a modest radiation boost improves 9-year survival without increasing toxicity, despite no improvement in pathologic complete response.

News All Time

‘A Tiny Blueberry’: How Ingestible Sensors Keep Shrinking

A new thermometer is powerful, accurate, and easily swallowed even by children. Inside the push to make the perfectly sized, perfectly powered ingestible device.

Anxiety May Undermine Treatment Response in Some GERD Cases

Higher anxiety is linked to poorer response to proton pump inhibitor treatment among patients with gastroesophageal reflux disease.

Older Adults Have Worse Lower GI Bleeding Outcomes

Older adults with lower gastrointestinal bleeding present with more severe disease and substantially higher 30-day mortality—yet most deaths stem not from bleeding itself, but from decompensation of underlying chronic conditions.

Vaccine to Prevent Pancreatic Cancer Shows Early Promise

The vaccine spurs a lasting immune response in people at a high risk for pancreatic cancer. Whether it staves off the disease remains to be seen.

Durvalumab Tied to Extended Biliary Tract Cancer OS Benefit

Researchers examine 4-year outcomes of the phase 3 TOPAZ-1 study.

Low-Volume PEG Wins for Inpatient Bowel Cleansing

PEG 1 L beats ‘more-is-better’ pre-colonoscopy regimens, demonstrating more high-quality cleansing and greater tolerability than 2-L and 4-L formulations.

Why the Painless Abdominal Bloating in Middle-Age Man?

Admitted for pyelonephritis, but his diagnostic journey is just beginning

Beware Aspiration Risk in Chronic Pot Users

A cautionary tale of gastroparesis-related aspiration in NPO patient with no other risk factors

Unusual Confluence of Two Rare Syndromes Results in Peculiar Symptoms

Interpretation of an ultrasound exam made all the difference in creating a treatment plan

Common Meds Linked to Reduced Immunotherapy Benefit in Lung Cancer Trial

— Results highlight importance of careful evaluation of concurrent medications, researchers say

Q&A: Managing GI Toxicities of Immunotherapy

Gastrointestinal side effects are among the most important issues to address with patients starting on immune checkpoint inhibitors.

Equitable IBD Care: Improving Interactions With Patients From the LGBTQ+ Community

Equitable IBD Care: Improving Interactions With Patients From the LGBTQ+ Community

Mastering Recent Advances in Targeted Therapy for GEP-NETs

Mastering Recent Advances in Targeted Therapy for GEP-NETs

Steatosis and Cardiovascular Events; Golimumab Biosimilar OK'd; Daily Stress and IBS

News and commentary from the world of gastroenterology and hepatology

GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

Accumulating evidence of possible benefit warrants randomized trials, experts say

Danish Duo's Maverick African Research Finds Its Moment in RFK Jr.'s Vaccine Policy

"They became more strident in saying that their findings were real," says one expert

Recommended News For You

Two medications might work better for breast cancers that are resistant to one.

"We Caught It Early": Advantage or Disadvantage?

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

Certain surgical gestures during prostate removal linked to better sexual function recovery

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Chemo causes lasting physical decline in breast cancer survivors

By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

Recommended Articles For You

Transformative Insights in Oncology in Daily Practice 

Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine 

Hematopoietic Lineage Commitment Through Single-Cell Functional Genomics: Insights, Mechanisms, and Clinical Implications 

A New Perspective on Spherocytosis: Uncovering Innovative Treatments 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Drop in credit score after cancer diagnosis linked to increased mortality

2.

Acupuncture may alleviate nocturia in men treated for prostate cancer

3.

The use of biomarkers in the treatment of breast lumps is at a crossroads.

4.

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

5.

Where Did This Very Painful Gluteal Mass Come From?

1.

Symptoms and Causes of Phlegmasia Cerulea Dolens: A Comprehensive Guide 

2.

The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery

3.

Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape

4.

Respiratory Ramifications of Systemic Disease: A Comprehensive Review

5.

Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

2.

Expert Perspectives on Hematology

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

4.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot